These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


574 related items for PubMed ID: 15367334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD.
    World J Gastroenterol; 2004 Dec 01; 10(23):3441-54. PubMed ID: 15526363
    [Abstract] [Full Text] [Related]

  • 5. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 6. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.
    Oncol Rep; 2012 Apr 01; 27(4):1135-41. PubMed ID: 22246327
    [Abstract] [Full Text] [Related]

  • 7. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct 01; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
    Qin Y, Liu JY, Li B, Sun ZL, Sun ZF.
    World J Gastroenterol; 2004 May 01; 10(9):1276-80. PubMed ID: 15112341
    [Abstract] [Full Text] [Related]

  • 10. Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas.
    Ohta T, Watanabe T, Katayama Y, Yoshino A, Yachi K, Ogino A, Komine C, Fukushima T.
    Oncol Rep; 2006 Nov 01; 16(5):957-63. PubMed ID: 17016577
    [Abstract] [Full Text] [Related]

  • 11. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
    Lind GE, Thorstensen L, Løvig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA.
    Mol Cancer; 2004 Oct 11; 3():28. PubMed ID: 15476557
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 14. Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.
    Dong SM, Pang JC, Poon WS, Hu J, To KF, Chang AR, Ng HK.
    J Neuropathol Exp Neurol; 2001 Aug 15; 60(8):808-16. PubMed ID: 11487055
    [Abstract] [Full Text] [Related]

  • 15. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P, Bello MJ, Arjona D, Lomas J, Alonso ME, De Campos JM, Vaquero J, Isla A, Gutierrez M, Rey JA.
    Int J Oncol; 2003 Mar 15; 22(3):601-8. PubMed ID: 12579314
    [Abstract] [Full Text] [Related]

  • 16. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW, Pang CP, To KF, Yu CB, Ng JS, Lam DS.
    Invest Ophthalmol Vis Sci; 2002 May 15; 43(5):1344-9. PubMed ID: 11980845
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R, Zoutman WH, Dijkman R, de Menezes RX, Commandeur S, Mulder AA, van der Velden PA, Vermeer MH, Willemze R, Yan PS, Huang TH, Tensen CP.
    J Clin Oncol; 2005 Jun 10; 23(17):3886-96. PubMed ID: 15897551
    [Abstract] [Full Text] [Related]

  • 18. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R, Zubor P, Janusicova V, Visnovsky J, Mendelova A, Kajo K, Lasabova Z, Plank L, Danko J.
    Oncol Rep; 2013 Dec 10; 30(6):2878-86. PubMed ID: 24068440
    [Abstract] [Full Text] [Related]

  • 19. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
    Kim H, Kim YH, Kim SE, Kim NG, Noh SH, Kim H.
    J Pathol; 2003 May 10; 200(1):23-31. PubMed ID: 12692837
    [Abstract] [Full Text] [Related]

  • 20. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.
    Palani M, Devan S, Arunkumar R, Vanisree AJ.
    Med Oncol; 2011 Dec 10; 28 Suppl 1():S445-52. PubMed ID: 20844987
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.